#USA #Frederick #Surplus Solutions #DCM BioServices #NMS Capital

Surplus Solutions Expands Technical Service Capabilities

Surplus Solutions LLC, a part of the NMS Capital portfolio, has recently made headlines with its strategic acquisition of DCM BioServices, a provider known for its exceptional services in laboratory automation maintenance, repair, and technical support. This acquisition, announced on July 6, 2026, is set to significantly enhance Surplus Solutions' technical service offerings, positioning the company for continued growth within the biotechnology and pharmaceutical sectors.

About DCM BioServices

Founded in 2011 and based in Frederick, Maryland, DCM BioServices has spent over a decade building a reputable presence in the life sciences industry. The company has serviced more than 3,000 instruments across over 200 laboratories nationwide. DCM Bio specializes in laboratory automation field service and boasts extensive expertise with equipment from renowned manufacturers such as Beckman Coulter, Agilent, Hamilton, Tecan, and Thermo Fisher Scientific. In addition to maintenance and repair services, DCM Bio provides various technical support options and full-coverage service agreements, aimed at maximizing instrument uptime and prolonging equipment lifespan.

Dave May, the founder and Director of Service and Automation at DCM BioServices, expressed enthusiasm about the acquisition, stating, "Joining Surplus Solutions felt like a natural next step, as a team that shares our commitment to customer service and has the infrastructure to take our technical service offering to the next level. I look forward to what we will build together."

Strategic Importance of the Acquisition

The CEO of Surplus Solutions, Joe Reale, emphasized that this acquisition marks a significant milestone in their strategy to develop a world-class equipment lifecycle management platform. By combining their equipment expertise with DCM Bio’s technical capabilities, Surplus Solutions aims to offer customers a comprehensive partner for the complete lifecycle of liquid handling and lab automation equipment. Reale stated, "DCM Bio's deep expertise in this highly specialized field makes them an exceptional addition to our platform, and we're thrilled to welcome the DCM Bio team."

The acquisition is anticipated to foster growth opportunities as preventive maintenance contracts continue to represent a compelling, recurring revenue source. David Peterson, a partner at NMS, noted the strategic alignment of DCM Bio’s services with Surplus Solutions’ existing customer relationships, asserting that the merger will enhance their service capabilities across the board.

The Road Ahead

DCM Bio's role in the combined entity will see the two companies leveraging their strengths to create a robust technical service infrastructure that not only benefits current clients but also attracts new business in the competitive life sciences sector. As the demand for efficient laboratory operations increases, this acquisition provides Surplus Solutions with the necessary tools to meet evolving market needs and customer expectations.

The financial details surrounding the acquisition remain undisclosed, but legal counsel for Surplus Solutions was handled by McDermott Will & Emery, while TPG Twin Brook Capital Partners provided financing for the transaction, ensuring a smooth transition.

Conclusion

In conclusion, the acquisition of DCM BioServices by Surplus Solutions is a strategic move that is likely to enhance the technical service offerings of both companies, positioning them for greater success in an increasingly competitive marketplace. With a commitment to maintaining high standards of customer service, both teams are set to embark on a journey of growth and innovation in the biotechnology and life sciences industries.